Bio-Techne news

The WiseView Research desk's stories that name Bio-Techne, the latest headlines about it, and the trades members of Congress and company insiders have disclosed. The TECH page →

  • Company earningsThermo Fisher Scientific tops Q3 estimates, but shares slide premarket

    Thermo Fisher beat EPS and revenue estimates for Q3, yet the stock fell before the open on October 21, 2026.

    WiseView Research desk · October 21, 2026 at 9:31 AM ET
  • HeadlinePress release: CMB.TECH fleet updateGlobeNewsWire · October 13, 2026 at 3:08 AM ET
  • HeadlineCMB.TECH SPECIAL GENERAL MEETING RESULTSGlobeNewsWire · October 8, 2026 at 9:10 AM ET
  • HeadlineINTURAI PROVIDES DEFENCE TECH COMPETITION RESULTS AND COMPANY UPDATEPRNewsWire · September 29, 2026 at 12:56 PM ET
  • CongressApril McClain Delaney sold $1,001 - $15,000 of TECHHouse · D-Maryland · traded Apr 8, 2026 · disclosed May 7, 2026
  • CongressApril McClain Delaney sold $1,001 - $15,000 of TECHHouse · D-Maryland · traded Mar 26, 2026 · disclosed Apr 8, 2026
  • CongressApril McClain Delaney sold $1,001 - $15,000 of TECHHouse · D-Maryland · traded Feb 24, 2026 · disclosed Mar 11, 2026
  • CongressApril Delaney sold $1,001 - $15,000 of TECHHouse · traded Jan 28, 2026 · disclosed Feb 3, 2026
  • CongressApril Delaney bought $1,001 - $15,000 of TECHHouse · traded Dec 2, 2025 · disclosed Jan 6, 2026
  • CongressApril Delaney bought $1,001 - $15,000 of TECHHouse · traded Dec 5, 2025 · disclosed Jan 6, 2026
  • CongressApril Delaney bought $1,001 - $15,000 of TECHHouse · traded Oct 22, 2025 · disclosed Nov 5, 2025
  • CongressApril Delaney sold $1,001 - $15,000 of TECHHouse · traded Aug 1, 2025 · disclosed Sep 3, 2025

Headlines link to their publishers. Members of Congress disclose ranges, not exact amounts, and may file weeks after the trade; insider filings are open-market purchases and sales from SEC Form 4. For information only, not investment advice.

Follow TECH in the terminal.

Membership details

14-day free trial · no card needed · nothing to cancel.

Then $83/mo billed annually — $997 once a year.

WiseView provides market data and research tools for educational purposes. Nothing here is investment advice. Past performance does not predict future results.